Composition comprising diacid derivatives and their use in the treatment of collagenic eye disorders
Abstract:
The present invention relates to novel pharmaceutical formulations. More specifically, the present invention relates to novel pharmaceutical formulations that are suitable for intraocular administration. The present invention also relates to the use of these formulations for the treatment of collagenic eye disorder such as, for example, the treatment of keratoconus.
Information query
Patent Agency Ranking
0/0